Greenwich LifeSciences, Inc. (GLSI) News
Follow Greenwich LifeSciences, Inc. (GLSI) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
FORM 4P GLSI - Greenwich LifeSciences, Inc.|DIRECTOR|OFFICER|10% OWNER - CEO and CFO: Patel SnehalP | 3,600 | $13.061 | $47,018
FORM 4P GLSI - Greenwich LifeSciences, Inc.|DIRECTOR|OFFICER|10% OWNER - CEO and CFO: Patel SnehalP | 3,600 | $13.061 | $47,018
EQUITY | Jul 27, 2026, 10:58 AM UTC
L
GLSI Greenwich Lifesciences announces approval to expand flamingo-01 into the United Kingdom
GLSI Greenwich Lifesciences announces approval to expand flamingo-01 into the United Kingdom
EQUITY | Jul 22, 2026, 10:35 AM UTC
L
GLSI +4% on Light volume following earlier PR: Greenwich Lifesciences Receives Approval From European Medicines Agency To Combine HLA-A*02,
GLSI +4% on Light volume following earlier PR: Greenwich Lifesciences Receives Approval From European Medicines Agency To Combine HLA-A*02, Non-HLA-A*02 Participants In Europe
EQUITY | Jul 16, 2026, 12:43 PM UTC